New
7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview · 2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Day 2
1 / 4
Latest
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Conference
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Watched
Conference
2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Conference
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Watched
Conference
2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Conference
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Watched
Conference
2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Conference
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Watched
Conference
2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Nursing Care for Patients Receiving Cellular & BsAb Therapies | Belal Alblowe | SSBMT 2026
Conference
Nursing Care for Patients Receiving Cellular & BsAb Therapies | Belal Alblowe | SSBMT 2026
Watched
Conference
2026
Nursing Care for Patients Receiving Cellular & BsAb Therapies | Belal Alblowe | SSBMT 2026
Belal Ali Alblowe, RN, MSN
Building a Safe and High-Performing BMT Program | Mohamed Basheer | SSBMT 2026
General
Building a Safe and High-Performing BMT Program | Mohamed Basheer | SSBMT 2026
Watched
General
2026
Building a Safe and High-Performing BMT Program | Mohamed Basheer | SSBMT 2026
Mohamed Basheer, RN, BMTCN
CAR-T Cell Therapy: Patient Journey | Belal AlBtoosh | SSBMT 2026
General
CAR-T Cell Therapy: Patient Journey | Belal AlBtoosh | SSBMT 2026
Watched
General
2026
CAR-T Cell Therapy: Patient Journey | Belal AlBtoosh | SSBMT 2026
Belal AlBtoosh
Outpatient Transplant for Lymphoma Patients | Hamza Al-Quraan | SSBMT 2026
Conference
Outpatient Transplant for Lymphoma Patients | Hamza Al-Quraan | SSBMT 2026
Watched
Conference
2026
Outpatient Transplant for Lymphoma Patients | Hamza Al-Quraan | SSBMT 2026
Hamza Al-Quraan, RN, MSN, CNS
7th Saudi Lymphoma/Myeloma and 10th Hematopathology Overview 2026 Conference 4 videos
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Conference
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Watched
Conference
2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Conference
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Watched
Conference
2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Conference
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Watched
Conference
2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Conference
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
Watched
Conference
2026
Saudi Lymphoma/Myeloma & Hematopathology Overview 2026
15th Annual Conference of the SSBMT/ EBMT 2026 2026 Conference 35 videos
Nursing Care for Patients Receiving Cellular & BsAb Therapies | Belal Alblowe | SSBMT 2026
Conference
Nursing Care for Patients Receiving Cellular & BsAb Therapies | Belal Alblowe | SSBMT 2026
Watched
Conference
2026
Nursing Care for Patients Receiving Cellular & BsAb Therapies | Belal Alblowe | SSBMT 2026
Belal Ali Alblowe, RN, MSN
Building a Safe and High-Performing BMT Program | Mohamed Basheer | SSBMT 2026
General
Building a Safe and High-Performing BMT Program | Mohamed Basheer | SSBMT 2026
Watched
General
2026
Building a Safe and High-Performing BMT Program | Mohamed Basheer | SSBMT 2026
Mohamed Basheer, RN, BMTCN
CAR-T Cell Therapy: Patient Journey | Belal AlBtoosh | SSBMT 2026
General
CAR-T Cell Therapy: Patient Journey | Belal AlBtoosh | SSBMT 2026
Watched
General
2026
CAR-T Cell Therapy: Patient Journey | Belal AlBtoosh | SSBMT 2026
Belal AlBtoosh
Outpatient Transplant for Lymphoma Patients | Hamza Al-Quraan | SSBMT 2026
Conference
Outpatient Transplant for Lymphoma Patients | Hamza Al-Quraan | SSBMT 2026
Watched
Conference
2026
Outpatient Transplant for Lymphoma Patients | Hamza Al-Quraan | SSBMT 2026
Hamza Al-Quraan, RN, MSN, CNS
Enhancing Transplantation Rates for Sickle Cell Disease | Maram Haddad | SSBMT 2026
Conference
Enhancing Transplantation Rates for Sickle Cell Disease | Maram Haddad | SSBMT 2026
Watched
Conference
2026
Enhancing Transplantation Rates for Sickle Cell Disease | Maram Haddad | SSBMT 2026
Maram Haddad, BSN, RN
Transforming Hematology Care: Acute Leukemia & Multiple Myeloma | S. Alkhraisat | SSBMT 2026
Conference
Transforming Hematology Care: Acute Leukemia & Multiple Myeloma | S. Alkhraisat | SSBMT 2026
Watched
Conference
2026
Transforming Hematology Care: Acute Leukemia & Multiple Myeloma | S. Alkhraisat | SSBMT 2026
Suha Alkhraisat, BSN, RN, CNS
The Impact of Novel Therapeutics on Clinical Nurse Education | Silvia Gnecchi | SSBMT 2026
Conference
The Impact of Novel Therapeutics on Clinical Nurse Education | Silvia Gnecchi | SSBMT 2026
Watched
Conference
2026
The Impact of Novel Therapeutics on Clinical Nurse Education | Silvia Gnecchi | SSBMT 2026
Silvia Gnecchi, RN, MScN
Malignant Hematology & Recent Update in HL (Hodgkin Lymphoma) | Izaskun Zeberio | SSBMT 2026
Conference
Malignant Hematology & Recent Update in HL (Hodgkin Lymphoma) | Izaskun Zeberio | SSBMT 2026
Watched
Conference
2026
Malignant Hematology & Recent Update in HL (Hodgkin Lymphoma) | Izaskun Zeberio | SSBMT 2026
Izaskun Zeberio Etxetxipia
Fourth SSBMT & SSH Combined Annual Conference 2026 Conference 22 videos
Lymphoma mimickers & Diagnostic Traps | Alfadel Alshaibani | 31 JAN 2026
General
Lymphoma mimickers & Diagnostic Traps | Alfadel Alshaibani | 31 JAN 2026
Watched
General
2026
Lymphoma mimickers & Diagnostic Traps | Alfadel Alshaibani | 31 JAN 2026
Overview on Platelets Products in Clinical Practice | Salwa Hindawi | 31 JAN 2026
General
Overview on Platelets Products in Clinical Practice | Salwa Hindawi | 31 JAN 2026
Watched
General
2026
Overview on Platelets Products in Clinical Practice | Salwa Hindawi | 31 JAN 2026
Cancer Associated Thrombosis (CAT) | Sarah Sewaralthahab | 31 JAN 2026
General
Cancer Associated Thrombosis (CAT) | Sarah Sewaralthahab | 31 JAN 2026
Watched
General
2026
Cancer Associated Thrombosis (CAT) | Sarah Sewaralthahab | 31 JAN 2026
Complicated cases of thrombosis – challenges in management | Ashraf Warsi | 31 JAN 2026
General
Complicated cases of thrombosis – challenges in management | Ashraf Warsi | 31 JAN 2026
Watched
General
2026
Complicated cases of thrombosis – challenges in management | Ashraf Warsi | 31 JAN 2026
Richter’s Transformation | Mohammed Almakadi | 31 JAN 2026
General
Richter’s Transformation | Mohammed Almakadi | 31 JAN 2026
Watched
General
2026
Richter’s Transformation | Mohammed Almakadi | 31 JAN 2026
Hodgkin Lymphoma–therapy sequencing in the era of upfront biologic therapy |Ahmed Barefah |31JAN2026
General
Hodgkin Lymphoma–therapy sequencing in the era of upfront biologic therapy |Ahmed Barefah |31JAN2026
Watched
General
2026
Hodgkin Lymphoma–therapy sequencing in the era of upfront biologic therapy |Ahmed Barefah |31JAN2026
Fixed duration Novel agents’ combinations in CLL upfront therapy | Ahmed Absi | 31 JAN 2026
General
Fixed duration Novel agents’ combinations in CLL upfront therapy | Ahmed Absi | 31 JAN 2026
Watched
General
2026
Fixed duration Novel agents’ combinations in CLL upfront therapy | Ahmed Absi | 31 JAN 2026
Neutrophilia other than CML | Hanan Hamed | 31 JAN 2026
General
Neutrophilia other than CML | Hanan Hamed | 31 JAN 2026
Watched
General
2026
Neutrophilia other than CML | Hanan Hamed | 31 JAN 2026
14th Annual Conference of the SSBMT 2026 Conference 1 video
Eosinophilic Updates to Old Approaches | Osman Radhwi | 30 JAN 2026
General
Eosinophilic Updates to Old Approaches | Osman Radhwi | 30 JAN 2026
Watched
General
2026
Eosinophilic Updates to Old Approaches | Osman Radhwi | 30 JAN 2026
13th Annual Conference of the SSBMT 2024 Conference 1 video
SSBMT & SSH COMBINED ANNUAL CONFERENCE
Conference
SSBMT & SSH COMBINED ANNUAL CONFERENCE
Watched
Conference
2024
SSBMT & SSH COMBINED ANNUAL CONFERENCE
Second SSBMT/SSH Combined Annual Conference 2024 Conference 2 videos
SSBMT & SSH COMBINED ANNUAL CONFERENCE
General
SSBMT & SSH COMBINED ANNUAL CONFERENCE
Watched
General
2024
SSBMT & SSH COMBINED ANNUAL CONFERENCE
SSBMT & SSH COMBINED ANNUAL CONFERENCE
General
SSBMT & SSH COMBINED ANNUAL CONFERENCE
Watched
General
2024
SSBMT & SSH COMBINED ANNUAL CONFERENCE
Webinar Series 76 videos
A New Era in Large B-Cell Lymphoma: Pushing the Frontiers of Care with CAR‑T Cell Therapy
Webinar
A New Era in Large B-Cell Lymphoma: Pushing the Frontiers of Care with CAR‑T Cell Therapy
Watched
Webinar
2026
A New Era in Large B-Cell Lymphoma: Pushing the Frontiers of Care with CAR‑T Cell Therapy
SSBMT Webinar Series - 20 June 2026
Webinar
SSBMT Webinar Series - 20 June 2026
Watched
Webinar
2026
SSBMT Webinar Series - 20 June 2026
SSBMT Webinar Series - 18 April 2026
Webinar
SSBMT Webinar Series - 18 April 2026
Watched
Webinar
2026
SSBMT Webinar Series - 18 April 2026
SSBMT Webinar Series - Role of Tecartus in MCL and ALL - 27 December 2025
Webinar
SSBMT Webinar Series - Role of Tecartus in MCL and ALL - 27 December 2025
Watched
Webinar
2025
SSBMT Webinar Series - Role of Tecartus in MCL and ALL - 27 December 2025
AI in Healthcare Webinar - MDS – A complex disease but should it remain as such?
Webinar
AI in Healthcare Webinar - MDS – A complex disease but should it remain as such?
Watched
Webinar
2025
AI in Healthcare Webinar - MDS – A complex disease but should it remain as such?
SSBMT Webinar Series - Yescarta in Real-World Evidence (RWE) - 08 November 2025
Webinar
SSBMT Webinar Series - Yescarta in Real-World Evidence (RWE) - 08 November 2025
Watched
Webinar
2025
SSBMT Webinar Series - Yescarta in Real-World Evidence (RWE) - 08 November 2025
SSBMT Webinar Series - Long-Term Follow-Up and Safety Management for Axi-Cel - 25 October 2025
Webinar
SSBMT Webinar Series - Long-Term Follow-Up and Safety Management for Axi-Cel - 25 October 2025
Watched
Webinar
2025
SSBMT Webinar Series - Long-Term Follow-Up and Safety Management for Axi-Cel - 25 October 2025
SSBMT Webinar Series (CAR T-Cell Therapy) - 14 October 2025
Webinar
SSBMT Webinar Series (CAR T-Cell Therapy) - 14 October 2025
Watched
Webinar
2025
SSBMT Webinar Series (CAR T-Cell Therapy) - 14 October 2025
Live Sessions 5 videos
SSBMT Live 01 OCT 2022
Live
SSBMT Live 01 OCT 2022
Watched
Live
2022
SSBMT Live 01 OCT 2022
SSBMT Live 01 OCT 2022
Live
SSBMT Live 01 OCT 2022
Watched
Live
2022
SSBMT Live 01 OCT 2022
SSBMT Live 30 SEP 2022
Live
SSBMT Live 30 SEP 2022
Watched
Live
2022
SSBMT Live 30 SEP 2022
SSBMT جمعية الخلايا الجذعية Live Stream
Live
SSBMT جمعية الخلايا الجذعية Live Stream
Watched
Live
2022
SSBMT جمعية الخلايا الجذعية Live Stream
SSBMT جمعية الخلايا الجذعية Live Stream
Live
SSBMT جمعية الخلايا الجذعية Live Stream
Watched
Live
2020
SSBMT جمعية الخلايا الجذعية Live Stream
Lectures · 2026 8 videos
CAR-T vs Bispecific Antibodies in Aggressive Lymphoma | Sameer Alamoudi | 30 JAN 2026
General
CAR-T vs Bispecific Antibodies in Aggressive Lymphoma | Sameer Alamoudi | 30 JAN 2026
Watched
General
2026
CAR-T vs Bispecific Antibodies in Aggressive Lymphoma | Sameer Alamoudi | 30 JAN 2026
Philadelphia positive ALL -Best First Line Therapy | Nahla Shihata | 30 JAN 2026
General
Philadelphia positive ALL -Best First Line Therapy | Nahla Shihata | 30 JAN 2026
Watched
General
2026
Philadelphia positive ALL -Best First Line Therapy | Nahla Shihata | 30 JAN 2026
1 Integration of Menin Inhibitors in the therapy of AML | Muteb Althomali | | 30 JAN 2026
General
1 Integration of Menin Inhibitors in the therapy of AML | Muteb Althomali | | 30 JAN 2026
Watched
General
2026
1 Integration of Menin Inhibitors in the therapy of AML | Muteb Althomali | | 30 JAN 2026
ALL:How does the future look like w/ Incorporation of upfront Novel therapies | Saleem Eldadah
General
ALL:How does the future look like w/ Incorporation of upfront Novel therapies | Saleem Eldadah
Watched
General
2026
ALL:How does the future look like w/ Incorporation of upfront Novel therapies | Saleem Eldadah
Frontline Management in Multiple Myeloma | Ayman Alhejazi | 30 JAN 2026
General
Frontline Management in Multiple Myeloma | Ayman Alhejazi | 30 JAN 2026
Watched
General
2026
Frontline Management in Multiple Myeloma | Ayman Alhejazi | 30 JAN 2026
HIV Associated Lymphomas | Hafiz Malhan | 30 JAN 2026
General
HIV Associated Lymphomas | Hafiz Malhan | 30 JAN 2026
Watched
General
2026
HIV Associated Lymphomas | Hafiz Malhan | 30 JAN 2026
Is there still a role for ASCT in Mantle Cell Lymphoma | Reyad Dada | 30 JAN 2026
General
Is there still a role for ASCT in Mantle Cell Lymphoma | Reyad Dada | 30 JAN 2026
Watched
General
2026
Is there still a role for ASCT in Mantle Cell Lymphoma | Reyad Dada | 30 JAN 2026
Now Is the Time to Improve Outcomes in Diffuse Large B-Cell Lymphoma | Mubarak Almansour| 30JAN 2026
General
Now Is the Time to Improve Outcomes in Diffuse Large B-Cell Lymphoma | Mubarak Almansour| 30JAN 2026
Watched
General
2026
Now Is the Time to Improve Outcomes in Diffuse Large B-Cell Lymphoma | Mubarak Almansour| 30JAN 2026
Lectures · 2025 74 videos
Day 2 18-ICML Highlights & Hematopathology Overview
General
Day 2 18-ICML Highlights & Hematopathology Overview
Watched
General
2025
Day 2 18-ICML Highlights & Hematopathology Overview
18-ICML Highlights & Hematopathology Overview
General
18-ICML Highlights & Hematopathology Overview
Watched
General
2025
18-ICML Highlights & Hematopathology Overview
07 Novel approaches for primary refractory DLBCL management | Dr . Bader Alahmari | 14 Sept 2024
General
07 Novel approaches for primary refractory DLBCL management | Dr . Bader Alahmari | 14 Sept 2024
Watched
General
2025
07 Novel approaches for primary refractory DLBCL management | Dr . Bader Alahmari | 14 Sept 2024
06 HSCT – local experience – EGYPT | Dr. Almetwaly Sultan | 14 Sept 2024
General
06 HSCT – local experience – EGYPT | Dr. Almetwaly Sultan | 14 Sept 2024
Watched
General
2025
06 HSCT – local experience – EGYPT | Dr. Almetwaly Sultan | 14 Sept 2024
05 HSCT – local experience – OMAN | Dr. Thuraya Al-Busaidi | 14 Sept 2024
General
05 HSCT – local experience – OMAN | Dr. Thuraya Al-Busaidi | 14 Sept 2024
Watched
General
2025
05 HSCT – local experience – OMAN | Dr. Thuraya Al-Busaidi | 14 Sept 2024
04 Strategies and challenges in R/R AML | Dr. Bader Alahmari | 14 Sept 2024
General
04 Strategies and challenges in R/R AML | Dr. Bader Alahmari | 14 Sept 2024
Watched
General
2025
04 Strategies and challenges in R/R AML | Dr. Bader Alahmari | 14 Sept 2024
03 Practical consideration in the management of DLBCL patients | Dr. David Lewis | 14 Sept 2024
General
03 Practical consideration in the management of DLBCL patients | Dr. David Lewis | 14 Sept 2024
Watched
General
2025
03 Practical consideration in the management of DLBCL patients | Dr. David Lewis | 14 Sept 2024
08 CAR T-cell Therapy – Local experience (KFSH&RC) | Dr. Ibrahim Al Ghemlas | 14 Sept 2024
General
08 CAR T-cell Therapy – Local experience (KFSH&RC) | Dr. Ibrahim Al Ghemlas | 14 Sept 2024
Watched
General
2025
08 CAR T-cell Therapy – Local experience (KFSH&RC) | Dr. Ibrahim Al Ghemlas | 14 Sept 2024
Lectures · 2024 101 videos
Saudi Lyphoma/Myeloma & Hematopathology Overview 2024 (Oct 26, 2024) Le Meridien Medina Hotel
General
Saudi Lyphoma/Myeloma & Hematopathology Overview 2024 (Oct 26, 2024) Le Meridien Medina Hotel
Watched
General
2024
Saudi Lyphoma/Myeloma & Hematopathology Overview 2024 (Oct 26, 2024) Le Meridien Medina Hotel
Saudi Lymphoma/Myeloma & Hematopathology Overview 2024 (OCt 25-26, 2024) Le Meridien Medina Hotel
General
Saudi Lymphoma/Myeloma & Hematopathology Overview 2024 (OCt 25-26, 2024) Le Meridien Medina Hotel
Watched
General
2024
Saudi Lymphoma/Myeloma & Hematopathology Overview 2024 (OCt 25-26, 2024) Le Meridien Medina Hotel
Saudi Lyphoma/Myeloma & Hematopathology Overview 2024 (Oct 25-26, 2024) Le Meridien Medina Hotel
General
Saudi Lyphoma/Myeloma & Hematopathology Overview 2024 (Oct 25-26, 2024) Le Meridien Medina Hotel
Watched
General
2024
Saudi Lyphoma/Myeloma & Hematopathology Overview 2024 (Oct 25-26, 2024) Le Meridien Medina Hotel
13th Annual SSBMT Conference
General
13th Annual SSBMT Conference
Watched
General
2024
13th Annual SSBMT Conference
13th Annual SSBMT Conference
General
13th Annual SSBMT Conference
Watched
General
2024
13th Annual SSBMT Conference
DLBCL – How to best sequence immunotherapies | Dr. John Apostolidis (16 Feb 2024)
General
DLBCL – How to best sequence immunotherapies | Dr. John Apostolidis (16 Feb 2024)
Watched
General
2024
DLBCL – How to best sequence immunotherapies | Dr. John Apostolidis (16 Feb 2024)
High prevalence of a rare bleeding disorder in Al-Madinah | Dr. Ahmad Tarawah (16 Feb 2024)
General
High prevalence of a rare bleeding disorder in Al-Madinah | Dr. Ahmad Tarawah (16 Feb 2024)
Watched
General
2024
High prevalence of a rare bleeding disorder in Al-Madinah | Dr. Ahmad Tarawah (16 Feb 2024)
Difficult Bleeding consultations in the Hospital | Dr. Mervat Mattar (16 Feb 2024)
General
Difficult Bleeding consultations in the Hospital | Dr. Mervat Mattar (16 Feb 2024)
Watched
General
2024
Difficult Bleeding consultations in the Hospital | Dr. Mervat Mattar (16 Feb 2024)
Lectures · 2023 65 videos
Role of community and companies in supporting research – Dr. Hani Alhashmi (February 18, 2023)
General
Role of community and companies in supporting research – Dr. Hani Alhashmi (February 18, 2023)
Watched
General
2023
Role of community and companies in supporting research – Dr. Hani Alhashmi (February 18, 2023)
Randomized Clinical Trials in Saudi Arabia – Dr. Mansoor Radwi (February 18, 2023)
General
Randomized Clinical Trials in Saudi Arabia – Dr. Mansoor Radwi (February 18, 2023)
Watched
General
2023
Randomized Clinical Trials in Saudi Arabia – Dr. Mansoor Radwi (February 18, 2023)
Academic Integrity & Manuscript Writing – Dr. Ali Hajeer (February 18, 2023)
General
Academic Integrity & Manuscript Writing – Dr. Ali Hajeer (February 18, 2023)
Watched
General
2023
Academic Integrity & Manuscript Writing – Dr. Ali Hajeer (February 18, 2023)
Scientific Writing – Dr. Naila Shaheen (February 18, 2023)
General
Scientific Writing – Dr. Naila Shaheen (February 18, 2023)
Watched
General
2023
Scientific Writing – Dr. Naila Shaheen (February 18, 2023)
Hematological Indices in the Adult Saudi Population – Dr. Naila Shaheen (February 18, 2023)
General
Hematological Indices in the Adult Saudi Population – Dr. Naila Shaheen (February 18, 2023)
Watched
General
2023
Hematological Indices in the Adult Saudi Population – Dr. Naila Shaheen (February 18, 2023)
Improved Survival of Adolecents &Young Adults Pts Aged 14-40 Yrs – Dr.Chokri Ben Lamine(Feb18, 2023)
General
Improved Survival of Adolecents &Young Adults Pts Aged 14-40 Yrs – Dr.Chokri Ben Lamine(Feb18, 2023)
Watched
General
2023
Improved Survival of Adolecents &Young Adults Pts Aged 14-40 Yrs – Dr.Chokri Ben Lamine(Feb18, 2023)
King Khalid University Hospital Lymphoid Database – Dr. Musa Alzahrani (February 18, 2023)
General
King Khalid University Hospital Lymphoid Database – Dr. Musa Alzahrani (February 18, 2023)
Watched
General
2023
King Khalid University Hospital Lymphoid Database – Dr. Musa Alzahrani (February 18, 2023)
Challenges in Starting and Maintaining Research Database – Dr. Ali Farsi (February 18, 2023)
General
Challenges in Starting and Maintaining Research Database – Dr. Ali Farsi (February 18, 2023)
Watched
General
2023
Challenges in Starting and Maintaining Research Database – Dr. Ali Farsi (February 18, 2023)
Lectures · 2022 30 videos
Novel therapies for GVHD - Zinaida Peric (June 3-4, 2022)
General
Novel therapies for GVHD - Zinaida Peric (June 3-4, 2022)
Watched
General
2022
Novel therapies for GVHD - Zinaida Peric (June 3-4, 2022)
AML: selected abstracts - Frederic Baron (June 3-4, 2022)
General
AML: selected abstracts - Frederic Baron (June 3-4, 2022)
Watched
General
2022
AML: selected abstracts - Frederic Baron (June 3-4, 2022)
MDS/SAA: selected abstracts - Regis Peffault de la Tour (June 3-4, 2022)
General
MDS/SAA: selected abstracts - Regis Peffault de la Tour (June 3-4, 2022)
Watched
General
2022
MDS/SAA: selected abstracts - Regis Peffault de la Tour (June 3-4, 2022)
ALL: selected abstracts - Sebastian Giebel (June 3-4, 2022)
General
ALL: selected abstracts - Sebastian Giebel (June 3-4, 2022)
Watched
General
2022
ALL: selected abstracts - Sebastian Giebel (June 3-4, 2022)
Autologous Stem Cell Transplantation for MM – Eastern Province Experience - Khalid Alanazi
General
Autologous Stem Cell Transplantation for MM – Eastern Province Experience - Khalid Alanazi
Watched
General
2022
Autologous Stem Cell Transplantation for MM – Eastern Province Experience - Khalid Alanazi
AML : Single center Experience - Ahmed Hegazi
General
AML : Single center Experience - Ahmed Hegazi
Watched
General
2022
AML : Single center Experience - Ahmed Hegazi
Toxicity analysis of single center experience with AVD-Bv - Amjad Al Thobaiti
General
Toxicity analysis of single center experience with AVD-Bv - Amjad Al Thobaiti
Watched
General
2022
Toxicity analysis of single center experience with AVD-Bv - Amjad Al Thobaiti
New horizons on CLL management - Paolo Ghia (11-12 Feb 2022)
General
New horizons on CLL management - Paolo Ghia (11-12 Feb 2022)
Watched
General
2022
New horizons on CLL management - Paolo Ghia (11-12 Feb 2022)
Lectures · 2021 35 videos
New Therapeutics in Non-Hodgkin Lymphoma: Dr. Anastasios Stathis (Switzerland) - 16-ICML Highlights
General
New Therapeutics in Non-Hodgkin Lymphoma: Dr. Anastasios Stathis (Switzerland) - 16-ICML Highlights
Watched
General
2021
New Therapeutics in Non-Hodgkin Lymphoma: Dr. Anastasios Stathis (Switzerland) - 16-ICML Highlights
Chronic Lymphocytic Leukemia : Dr. Davide Rossi (Switzerland) - 16-ICML Highlights - 08 Oct 2021
General
Chronic Lymphocytic Leukemia : Dr. Davide Rossi (Switzerland) - 16-ICML Highlights - 08 Oct 2021
Watched
General
2021
Chronic Lymphocytic Leukemia : Dr. Davide Rossi (Switzerland) - 16-ICML Highlights - 08 Oct 2021
Program Overview: Dr. Mubarak Al Mansour, Chairman,Scientific Committee, 16-ICML Highlights (8Oct21)
General
Program Overview: Dr. Mubarak Al Mansour, Chairman,Scientific Committee, 16-ICML Highlights (8Oct21)
Watched
General
2021
Program Overview: Dr. Mubarak Al Mansour, Chairman,Scientific Committee, 16-ICML Highlights (8Oct21)
Opening Remarks: Prof. Ahmed Alaskar, President, SSBMT on the 16-ICML Highlights (Hybrid event).
General
Opening Remarks: Prof. Ahmed Alaskar, President, SSBMT on the 16-ICML Highlights (Hybrid event).
Watched
General
2021
Opening Remarks: Prof. Ahmed Alaskar, President, SSBMT on the 16-ICML Highlights (Hybrid event).
Lymphoma Imaging - Dr. Emanuele Zucca (Switzerland) - 16-ICML Highlights - 08 Oct 2021
General
Lymphoma Imaging - Dr. Emanuele Zucca (Switzerland) - 16-ICML Highlights - 08 Oct 2021
Watched
General
2021
Lymphoma Imaging - Dr. Emanuele Zucca (Switzerland) - 16-ICML Highlights - 08 Oct 2021
Summary presentation by Dr. Mohsen Al Zahrani (KAMC-Riyadh) - 16-ICML Highlights - 08 October 2021
General
Summary presentation by Dr. Mohsen Al Zahrani (KAMC-Riyadh) - 16-ICML Highlights - 08 October 2021
Watched
General
2021
Summary presentation by Dr. Mohsen Al Zahrani (KAMC-Riyadh) - 16-ICML Highlights - 08 October 2021
Aggressive Lymphomas: Dr. Anastasios Stathis (Switzerland) - 16-ICML Highlights - 08 Oct 2021
General
Aggressive Lymphomas: Dr. Anastasios Stathis (Switzerland) - 16-ICML Highlights - 08 Oct 2021
Watched
General
2021
Aggressive Lymphomas: Dr. Anastasios Stathis (Switzerland) - 16-ICML Highlights - 08 Oct 2021
Optimising outcomes in cutaneous T-cell lymphoma: Dr. Pier Luigi Zinzani (Italy) - 08 Oct 2021
General
Optimising outcomes in cutaneous T-cell lymphoma: Dr. Pier Luigi Zinzani (Italy) - 08 Oct 2021
Watched
General
2021
Optimising outcomes in cutaneous T-cell lymphoma: Dr. Pier Luigi Zinzani (Italy) - 08 Oct 2021
Lectures · 2020 2 videos
Is Warfarin Dead as a Treatment for New Venous Thromboembolism, Yes or No - 29 August 2020
General
Is Warfarin Dead as a Treatment for New Venous Thromboembolism, Yes or No - 29 August 2020
Watched
General
2020
Is Warfarin Dead as a Treatment for New Venous Thromboembolism, Yes or No - 29 August 2020
How I Treat Acute Myeloid Leukemia - 18 July 2020
General
How I Treat Acute Myeloid Leukemia - 18 July 2020
Watched
General
2020
How I Treat Acute Myeloid Leukemia - 18 July 2020
Lectures · 2019 2 videos
متبرعين بالخلايا الجذعية
General
متبرعين بالخلايا الجذعية
Watched
General
2019
متبرعين بالخلايا الجذعية
SSBMT جمعية الخلايا الجذعية
كيفية الانضمام إلى السجل السعودي للمتبرعين بالخلايا الجذعيه
General
كيفية الانضمام إلى السجل السعودي للمتبرعين بالخلايا الجذعيه
Watched
General
2019
كيفية الانضمام إلى السجل السعودي للمتبرعين بالخلايا الجذعيه
SSBMT جمعية الخلايا الجذعية
Lectures · 2018 20 videos
Saudi Lymphoma Myeloma 16 Current Paradigms on Management of Relapsed Multiple Myeloma
General
Saudi Lymphoma Myeloma 16 Current Paradigms on Management of Relapsed Multiple Myeloma
Watched
General
2018
Saudi Lymphoma Myeloma 16 Current Paradigms on Management of Relapsed Multiple Myeloma
Saudi Lymphoma Myeloma 15 DLBCL, Improving Outcome in High risk Disease
General
Saudi Lymphoma Myeloma 15 DLBCL, Improving Outcome in High risk Disease
Watched
General
2018
Saudi Lymphoma Myeloma 15 DLBCL, Improving Outcome in High risk Disease
Saudi Lymphoma Myeloma 14 Primary CNS lymphoma
General
Saudi Lymphoma Myeloma 14 Primary CNS lymphoma
Watched
General
2018
Saudi Lymphoma Myeloma 14 Primary CNS lymphoma
Saudi Lymphoma Myeloma 05 Geriatric Hematology in lymphoma
General
Saudi Lymphoma Myeloma 05 Geriatric Hematology in lymphoma
Watched
General
2018
Saudi Lymphoma Myeloma 05 Geriatric Hematology in lymphoma
Saudi Lymphoma Myeloma 13 Lymphoma in the era of precision Oncology
General
Saudi Lymphoma Myeloma 13 Lymphoma in the era of precision Oncology
Watched
General
2018
Saudi Lymphoma Myeloma 13 Lymphoma in the era of precision Oncology
Saudi Lymphoma Myeloma 12 Immunotherapy in Myeloma Past, Present & Future
General
Saudi Lymphoma Myeloma 12 Immunotherapy in Myeloma Past, Present & Future
Watched
General
2018
Saudi Lymphoma Myeloma 12 Immunotherapy in Myeloma Past, Present & Future
Saudi Lymphoma Myeloma 11 Burkitt’s Lymphoma, KAMC J
General
Saudi Lymphoma Myeloma 11 Burkitt’s Lymphoma, KAMC J
Watched
General
2018
Saudi Lymphoma Myeloma 11 Burkitt’s Lymphoma, KAMC J
Saudi Lymphoma Myeloma 10 WHO update of T cell lymphomas
General
Saudi Lymphoma Myeloma 10 WHO update of T cell lymphomas
Watched
General
2018
Saudi Lymphoma Myeloma 10 WHO update of T cell lymphomas
0:00 / 0:00
Cookies on this site

This website uses only the cookies it needs to work — none for advertising or tracking. YouTube sets its own only when you play a video. Privacy Policy

Privacy Policy